Physician profile
Mario Wassel
NPI 1922561273
$3,548.94
in general payments reported to CMS, 2019-2025
36 companies · $1,625 in 2025
The $1,625 reported for 2025 was more than what 93% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $244 · 2023: $673 · 2024: $1,008 · 2025: $1,625.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,305.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $459.38 | 2025 | Farxiga, Breztri, Fasenra |
| Bayer Healthcare Pharmaceuticals INC. | $413.05 | 2022-2025 | |
| Amgen INC. | $397.73 | 2022-2025 | Krystexxa, Repatha, Otezla |
| Baxter Healthcare | $261.70 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Pfizer INC. | $160.16 | 2022-2025 | |
| Lilly USA, LLC | $151.33 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Harmony Biosciences LLC | $139.07 | 2024-2025 | |
| Glaxosmithkline, LLC. | $134.02 | 2023-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.41 | 2022-2025 | Jardiance, Spiriva Respimat, Stiolto Respimat |
| Jazz Pharmaceuticals INC. | $103.99 | 2022-2024 | |
| Abbott Laboratories | $100.01 | 2024-2025 | Freestyle Libre 2, Freestyle Libre 3, Infinity |
| Verona Pharma, INC. | $96.19 | 2025 | Ohtuvayre |
| Novo Nordisk INC | $93.24 | 2022-2024 | Rivfloza, Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $91.23 | 2023-2025 | Jynarque, Voyxact, Nuedexta |
| Grifols USA, LLC | $90.42 | 2024-2025 | Prolastin-C Liquid |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $72.02 | 2023-2025 | Watchman Flx, Watchman Access System |
| Exact Sciences Corporation | $71.92 | 2023-2025 | Cologuard Collection Kit |
| Mallinckrodt Hospital Products INC. | $63.65 | 2025 | Acthar |
| Novartis Pharmaceuticals Corporation | $63.33 | 2023-2025 | |
| Optinose US, INC. | $60.53 | 2024-2025 | |
| Electromed, INC. | $49.61 | 2025 | Smartvest |
| Ani Pharmaceuticals, INC. | $42.38 | 2024-2025 | Purified Cortrophin Gel |
| Dexcom, INC. | $41.71 | 2023-2024 | Dexcom G6 Transmitter |
| Ardelyx, INC. | $27.58 | 2024 | Ibsrela |
| Akebia Therapeutics INC | $27.18 | 2025 | Vafseo |
| Edwards Lifesciences Corporation | $26.42 | 2024 | |
| Calliditas Therapeutics US INC. | $25.04 | 2022 | |
| Philips North America LLC | $23.46 | 2024 | (Ak6) Vest Therapy |
| Ibsa Pharma INC. | $21.86 | 2025 | Licart, Tirosint, Flector |
| Mylan Specialty L.P. | $20.93 | 2024 | Yupelri |
| Inspire Medical Systems, INC. | $20.31 | 2025 | Inspire |
| Scpharmaceuticals INC. | $19.15 | 2025 | |
| Janssen Pharmaceuticals, INC | $18.54 | 2024 | Xarelto |
| Xeris Pharmaceuticals, INC. | $17.69 | 2025 | Gvoke Hypopen |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.93 | 2024 | Xifaxan |
| Abbvie INC. | $14.77 | 2023 | Qulipta, Ubrelvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mario Wassel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.